FI881773A7 - Medel foer prevention och behandling av retrovirusinfektioner. - Google Patents

Medel foer prevention och behandling av retrovirusinfektioner. Download PDF

Info

Publication number
FI881773A7
FI881773A7 FI881773A FI881773A FI881773A7 FI 881773 A7 FI881773 A7 FI 881773A7 FI 881773 A FI881773 A FI 881773A FI 881773 A FI881773 A FI 881773A FI 881773 A7 FI881773 A7 FI 881773A7
Authority
FI
Finland
Prior art keywords
infektioner
retrovirus
prevention
medel foer
behandling
Prior art date
Application number
FI881773A
Other languages
English (en)
Finnish (fi)
Other versions
FI881773A0 (fi
Inventor
Patrick Thomas Prendergast
Original Assignee
Colthurst Ltd
Patrick Thomas Prendergast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colthurst Ltd, Patrick Thomas Prendergast filed Critical Colthurst Ltd
Publication of FI881773A0 publication Critical patent/FI881773A0/fi
Publication of FI881773A7 publication Critical patent/FI881773A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI881773A 1987-04-16 1988-04-15 Medel foer prevention och behandling av retrovirusinfektioner. FI881773A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE99787 1987-04-16
IE228987 1987-08-27

Publications (2)

Publication Number Publication Date
FI881773A0 FI881773A0 (fi) 1988-04-15
FI881773A7 true FI881773A7 (fi) 1988-10-17

Family

ID=26319024

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881773A FI881773A7 (fi) 1987-04-16 1988-04-15 Medel foer prevention och behandling av retrovirusinfektioner.

Country Status (23)

Country Link
US (1) US4956355A (cs)
JP (1) JP2577771B2 (cs)
KR (1) KR960014988B1 (cs)
AT (1) AT401470B (cs)
AU (1) AU608824B2 (cs)
BE (1) BE1004315A5 (cs)
CA (1) CA1325594C (cs)
CH (1) CH675358A5 (cs)
DE (1) DE3812595C2 (cs)
DK (1) DK175582B1 (cs)
FI (1) FI881773A7 (cs)
FR (1) FR2615394B1 (cs)
GB (1) GB2204237B (cs)
GR (1) GR1002240B (cs)
IL (1) IL86089A (cs)
IT (1) IT1227073B (cs)
LU (1) LU87202A1 (cs)
NL (1) NL194728C (cs)
NZ (1) NZ224272A (cs)
OA (1) OA08729A (cs)
PH (1) PH25907A (cs)
PT (1) PT87259B (cs)
SE (1) SE503482C2 (cs)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687692T2 (de) * 1985-11-13 1993-05-19 Japan Res Dev Corp Geschlechtshormone zur behandlung von immun-mangel-krankheiten.
US5356900A (en) * 1986-10-07 1994-10-18 Bernard Bihari Method of treating chronic herpes virus infections using an opiate receptor antagonist
US6638894B1 (en) * 1987-01-09 2003-10-28 Lucent Technologies Inc. Devices and systems based on novel superconducting material
EP0309519B1 (en) * 1987-04-09 1992-07-08 FISONS plc Pharmaceutical compositions containing pentamidine
US5204113A (en) * 1987-04-09 1993-04-20 Fisons Plc Pharmaceutical compositions containing pentamidine
US5077284A (en) * 1988-12-30 1991-12-31 Loria Roger M Use of dehydroepiandrosterone to improve immune response
US5407684A (en) * 1988-12-30 1995-04-18 Virginia Commonwealth University Use of DHEA as a medicinal
WO1991004030A1 (en) * 1989-09-25 1991-04-04 University Of Utah Use of steroid hormones in compositions for inducing t cell lymphokine production
US5562910A (en) * 1989-09-25 1996-10-08 University Of Utah Research Foundation Vaccine compositions and method for enhancing an immune response
US5824313A (en) * 1989-09-25 1998-10-20 University Of Utah Research Foundation Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
US5518725A (en) * 1989-09-25 1996-05-21 University Of Utah Research Foundation Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
US5837269A (en) * 1989-09-25 1998-11-17 University Of Utah Research Foundation Vaccine compositions and method for enhancing an immune response
US5753237A (en) * 1989-09-25 1998-05-19 University Of Utah Research Foundation Method for augmenting immunological responses
US5162361A (en) * 1990-04-10 1992-11-10 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Method of treating diseases associated with elevated levels of interleukin 1
US5292730A (en) * 1990-08-29 1994-03-08 Humanetics Corporation Modulation of immune system with Δ5-androstenes
IE63418B1 (en) * 1990-09-10 1995-04-19 Elan Corp Plc Progression risk of HIV by assay of dehydroepiandrosterone in body fluid
US5206008A (en) * 1991-04-15 1993-04-27 Virginia Commonwealth University Enhancement of immune response
JPH05317041A (ja) * 1991-06-05 1993-12-03 Nippon Oil Co Ltd 動物細胞増殖促進剤及び無血清培地
US5230897A (en) * 1991-10-31 1993-07-27 G. D. Searle & Co. Transdermal pentamidine
WO1993016704A1 (en) * 1992-02-24 1993-09-02 East Carolina University Method of inhibiting carcinogenesis by treatment with dehydroepiandrosterone and analogs thereof
CA2134228A1 (en) * 1992-05-01 1993-11-11 Raymond A. Daynes Compositions and methods for regulating il-6 production in vivo
US5346997A (en) * 1992-08-26 1994-09-13 Murphy James G Agents for complexing sodium under biological conditions
FR2696934B1 (fr) * 1992-10-20 1995-06-02 Conservatoire Nal Arts Metiers Dérivés de stéroïdes naturels 3B hydroxyles ayant des propriétés de déclenchement et de stimulation de l'immunité, composition les contenant et procédé pour les obtenir.
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
WO1994016709A2 (en) * 1993-01-19 1994-08-04 Endorecherche Inc. Therapeutic uses and delivery systems of dehydroepiandrosterone
US5439899A (en) * 1993-03-10 1995-08-08 Purdue Research Foundation Cosalane and related compounds having activity against aids and aids-related infections
US5407927A (en) * 1993-04-16 1995-04-18 The Regents Of The University Of California Treatment of mild depression and restoration of IGF-I levels in aging by dehydroepiandrosterone
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
EP0752872B1 (en) * 1994-04-05 2008-10-29 Morré, D. James Nadh oxidase as a target in diagnosis and therapy
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
US7893044B2 (en) * 1995-02-24 2011-02-22 Epigenesis Pharmaceutical, Inc. Composition and method for altering levels of or sensitivity to adenosine with analogs of dehydroepiandrosterone
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
CA2244535A1 (en) * 1995-05-15 2000-01-30 Avon Products, Inc. Novel uses for ascorbyl-phosphoryl-cholesterol in topical compositions
US6162450A (en) * 1995-05-15 2000-12-19 Avon Products, Inc. Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
BR9608158A (pt) * 1996-05-14 1999-02-09 Avon Prod Inc Ascorbil-fosforil-colesterol
GB9612990D0 (en) * 1996-06-20 1996-08-21 Stanford Rock Ltd Compositions and methods for the treatment of chronic infections
US5885977A (en) * 1997-01-15 1999-03-23 Humanetics Corporation Use of Δ5 androstenes in the treatment of HIV wasting syndrome
US5902593A (en) * 1997-10-01 1999-05-11 Kent; Frances B. Topically applied personal lubricant containing benzalkonium chloride as the active ingredient
AU775614B2 (en) * 1998-11-24 2004-08-05 Harbor Biosciences, Inc. Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis C virus and other togaviruses
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US20070129282A1 (en) * 1998-11-24 2007-06-07 Ahlem Clarence N Pharmaceutical treatments and compositions
HK1043319A1 (zh) * 1998-11-24 2002-09-13 霍利斯--伊登医药公司 17-酮甾类化合物及其衍生物、代谢产物和前体在虐疾的治疗以及非洲和美洲锥虫病的治疗中的应用
US20060079492A1 (en) * 1999-10-25 2006-04-13 Ahlem Clarence N Compositions and treatment methods
AU1923500A (en) * 1998-11-27 2000-06-19 Hollis-Eden Pharmaceuticals, Inc. Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in treatment of toxoplasmosis and in the treatment of cryptosporidiosis
EP1163256B1 (en) * 1999-03-23 2004-02-18 Hollis-Eden Pharmaceuticals Inc. Hemihydrate of 16.alpha.-bromoepiandrosterone
EP1422234A3 (en) * 1999-03-23 2010-12-08 Harbor BioSciences, Inc. Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
FR2792201B1 (fr) * 1999-04-15 2001-11-02 Donatien Mavoungou Procede du renforcement immunitaire et du developpement d'un transporteur lipidique pour une therapie genique anti-vih et anti-bacterienne
US20050245502A1 (en) * 1999-08-23 2005-11-03 Phoenix Biosciences Treatments for viral infections
US7479498B2 (en) * 1999-08-23 2009-01-20 Phoenix Biosciences, Inc. Treatments for viral infections
EP2322182A1 (en) 1999-09-30 2011-05-18 Harbor BioSciences, Inc. Androstenol derivatives as androgen receptor modulator
WO2002085296A2 (en) * 2001-04-24 2002-10-31 Epigenesis Pharmaceuticals, Inc. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
BR0311883A (pt) * 2002-06-17 2005-04-05 Epigenesis Pharmaceuticals Llc Recipiente selado, kit, e, métodos para a profilaxia ou tratamento da asma, para a profilaxia ou tratamento da doença pulmonar obstrutiva crÈnica, para a redução ou exaustão da adenosina em um tecido do paciente e para profilaxia ou tratamento de um distúrbio ou condição associada com nìveis altos de adenosina ou sensibilidade à adenosina em um tecido do paciente
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050113318A1 (en) * 2003-07-31 2005-05-26 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
US20090263381A1 (en) * 2003-07-31 2009-10-22 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
US20050101545A1 (en) * 2003-07-31 2005-05-12 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090285900A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026879A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026848A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20050026884A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090297611A1 (en) * 2003-07-31 2009-12-03 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090285899A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20050043282A1 (en) * 2003-07-31 2005-02-24 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026881A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050026880A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005200A (en) * 1975-07-17 1977-01-25 Kanebo, Ltd. Method for improving the maturity of the parturient canal and the sensitivity to oxytocin
SE439586B (sv) * 1975-09-05 1985-06-24 Kanebo Ltd Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
US4518595A (en) * 1983-07-19 1985-05-21 The Jackson Laboratory Method for treating diabetes using DHEA compounds
AU582122B2 (en) * 1983-08-02 1989-03-16 Research Corporation Steroids useful as anti-cancer,anti-obesity, anti-hyperglycemic,anti-autoimmune and anti-hyperchlesterolemic agents
US4507289A (en) * 1983-12-28 1985-03-26 Progenics, Inc. Treatment of diabetes and other symptoms of hypercorticoidism using a synergistic combination of etiocholanolones and estrogen
US4602008A (en) * 1984-12-14 1986-07-22 Progenics, Inc. Alkylated etiocholanolones and use as an anti-diabetic, anti-obesity and erythropoietic agent
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US4628052A (en) * 1985-05-28 1986-12-09 Peat Raymond F Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
NL8502571A (nl) * 1985-09-20 1987-04-16 Akzo Nv Steroiden met immunomodulerende eigenschappen.
DE3687692T2 (de) * 1985-11-13 1993-05-19 Japan Res Dev Corp Geschlechtshormone zur behandlung von immun-mangel-krankheiten.

Also Published As

Publication number Publication date
CH675358A5 (cs) 1990-09-28
DK208188A (da) 1988-10-17
FI881773A0 (fi) 1988-04-15
PT87259B (pt) 1992-08-31
SE8801406D0 (sv) 1988-04-15
IT1227073B (it) 1991-03-14
JP2577771B2 (ja) 1997-02-05
PT87259A (pt) 1988-05-01
NL194728B (nl) 2002-09-02
ATA98488A (de) 1996-02-15
SE8801406L (sv) 1988-10-17
NL194728C (nl) 2003-01-07
AU608824B2 (en) 1991-04-18
GB2204237A (en) 1988-11-09
KR880012233A (ko) 1988-11-26
NL8800926A (nl) 1988-11-16
DE3812595C2 (de) 1997-07-03
DE3812595A1 (de) 1988-10-27
GR880100248A (el) 1989-01-31
IL86089A0 (en) 1988-09-30
GR1002240B (en) 1996-04-22
PH25907A (en) 1991-12-19
LU87202A1 (fr) 1988-11-17
NZ224272A (en) 1991-09-25
AT401470B (de) 1996-09-25
AU1467888A (en) 1988-10-20
BE1004315A5 (fr) 1992-11-03
JPS6425722A (en) 1989-01-27
US4956355A (en) 1990-09-11
FR2615394A1 (fr) 1988-11-25
GB2204237B (en) 1991-02-06
GB8808864D0 (en) 1988-05-18
KR960014988B1 (ko) 1996-10-23
SE503482C2 (sv) 1996-06-24
DK175582B1 (da) 2004-12-13
IT8847858A0 (it) 1988-04-15
OA08729A (en) 1989-03-31
IL86089A (en) 1992-11-15
FR2615394B1 (fr) 1994-09-23
CA1325594C (en) 1993-12-28
DK208188D0 (da) 1988-04-15

Similar Documents

Publication Publication Date Title
FI881773A7 (fi) Medel foer prevention och behandling av retrovirusinfektioner.
FI883036L (fi) Foerfarande och medel foer framstaellning av en tandbrygga.
FI882742L (fi) Vaordande medel och dessa innehaollande kompositioner.
FI891407A7 (fi) Anordning foer svaellning av naeringsaemnen, njutningsmedel och liknande.
FI883545A7 (fi) Foerfarande foer framstaellning av snoe foer artificiella banor foer utfoers- och terraengskidning och medel foer utfoerande av foerfarandet.
FI892032L (fi) Elektrotermiskt medel och foerfarande foer loesgoering av tandstaellning.
FI880748A7 (fi) Foerfarande foer framstaellning av naftalen-derivat anvaendbara saosom antiallergiska och antiinflammatoriska medel.
FI881126A0 (fi) Medel foer bekaempning av insekter och kvalster.
FI891718L (fi) Foerfarande foer att befria cellblandningar och vaevnader av icke-oenskade populationer.
FI87024B (fi) Foerfarande foer styrning av en kortsluten asynkronmotor och styrkrets.
FI885584L (fi) Foerfarande och medel foer konservering av hoe.
FI870287L (fi) Paelsdjursfoder och foerfarande foer framstaellning av detsamma.
FI871999L (fi) Traeimpregneringsmedel och foerfarande foer deras framstaellning.
FI890006L (fi) Medel och foerfarande foer permanentning av haor eller avlaegsnande av haorvaext.
FI884107A0 (fi) Saosom antibakteriella medel anvaendbara 4-oxo-3-kinolin-karboxyl-syror och deras framstaellning.
FI894029L (fi) Medel foer fixering av frisyren och foer haorvaord.
FI894855A0 (fi) Behandling av vattensystem foer att hindra korrosion och pannstensbildning.
FI875670A0 (fi) Foerfarande och anordning foer att goera virkessatser av en virkesstroem.
FI870184A0 (fi) Akustiskt stroemningsmaetningsfoerfarande och anordning foer tillaempning av detta.
FI882382A7 (fi) Biostimulerande matsmaeltningsmedel och foerfarande foer framstaellning daerav.
FI870747A7 (fi) Foerfarande och anordning foer foerbaettring av reglering och behandling av fibersuspensionsstroemning.
FI882105L (fi) Foerfarande foer kvantitativ bestaemning av serumproteiner i kroppsvaetskor och medel foer utfoerande av foerfarandet.
FI883934A7 (fi) Saett att genomfoera en sulfatcellulosaprocess och en anlaeggning foer genomfoering av saettet.
FI873082L (fi) Saett och medel foer anrikning av karbonatmineral.
FI882809L (fi) Profylaktiskt medel foer kontroll av veneriska sjukdomar.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: COLTHURST LIMITED

Owner name: PRENDERGAST, PATRICK THOMAS